Robert C. Unfer

986 total citations
18 papers, 457 citations indexed

About

Robert C. Unfer is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Robert C. Unfer has authored 18 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Infectious Diseases. Recurrent topics in Robert C. Unfer's work include Virus-based gene therapy research (7 papers), Viral Infections and Outbreaks Research (5 papers) and RNA Interference and Gene Delivery (5 papers). Robert C. Unfer is often cited by papers focused on Virus-based gene therapy research (7 papers), Viral Infections and Outbreaks Research (5 papers) and RNA Interference and Gene Delivery (5 papers). Robert C. Unfer collaborates with scholars based in United States, United Kingdom and Israel. Robert C. Unfer's co-authors include Surya K. Mallapragada, Charles J. Link, Tatiana Seregina, Gabriela R. Rossi, M. Javad Aman, Kelly L. Warfield, Mario R. Mautino, Nicholas N. Vahanian, Hong Vu and Sergey Shulenin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biomaterials.

In The Last Decade

Robert C. Unfer

18 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert C. Unfer United States 14 158 138 100 83 58 18 457
Emma Andersson Nordahl Sweden 9 229 1.4× 69 0.5× 291 2.9× 48 0.6× 26 0.4× 9 603
P Orsolini Italy 12 101 0.6× 104 0.8× 48 0.5× 36 0.4× 31 0.5× 31 423
С. В. Хайдуков Russia 11 146 0.9× 60 0.4× 172 1.7× 22 0.3× 39 0.7× 60 387
Nehal Mohamed United States 11 264 1.7× 98 0.7× 55 0.6× 64 0.8× 12 0.2× 16 439
Ans De Beuckelaer Belgium 13 441 2.8× 106 0.8× 369 3.7× 89 1.1× 26 0.4× 14 758
Melanie Reschke United States 6 155 1.0× 169 1.2× 101 1.0× 22 0.3× 60 1.0× 8 429
Marc Douaisi United States 11 179 1.1× 128 0.9× 116 1.2× 22 0.3× 15 0.3× 15 456
David Tabatadze United States 12 278 1.8× 108 0.8× 20 0.2× 47 0.6× 25 0.4× 24 541
Thomas Hagan United States 8 246 1.6× 138 1.0× 281 2.8× 26 0.3× 47 0.8× 12 581
Bruno B. Bordier United States 12 289 1.8× 196 1.4× 46 0.5× 46 0.6× 88 1.5× 14 713

Countries citing papers authored by Robert C. Unfer

Since Specialization
Citations

This map shows the geographic impact of Robert C. Unfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Unfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Unfer more than expected).

Fields of papers citing papers by Robert C. Unfer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Unfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Unfer. The network helps show where Robert C. Unfer may publish in the future.

Co-authorship network of co-authors of Robert C. Unfer

This figure shows the co-authorship network connecting the top 25 collaborators of Robert C. Unfer. A scholar is included among the top collaborators of Robert C. Unfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert C. Unfer. Robert C. Unfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Vu, Hong, Sergey Shulenin, Allen Grolla, et al.. (2015). Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans. Antiviral Research. 126. 55–61. 12 indexed citations
3.
Warfield, Kelly L., John M. Dye, Jay Wells, et al.. (2015). Homologous and Heterologous Protection of Nonhuman Primates by Ebola and Sudan Virus-Like Particles. PLoS ONE. 10(3). e0118881–e0118881. 45 indexed citations
4.
Warfield, Kelly L., Julia E. Biggins, Robert C. Unfer, et al.. (2014). Vaccinating captive chimpanzees to save wild chimpanzees. Proceedings of the National Academy of Sciences. 111(24). 8873–8876. 28 indexed citations
5.
Hu, Lei, Yuhong Zeng, Luisa Yee, et al.. (2011). Biophysical Characterization and Conformational Stability of Ebola and Marburg Virus-Like Particles. Journal of Pharmaceutical Sciences. 100(12). 5156–5173. 22 indexed citations
6.
Vilensky, Rita, et al.. (2007). Colloidally stable novel copolymeric system for gene delivery in complete growth media. Journal of Controlled Release. 121(1-2). 28–37. 25 indexed citations
7.
Unfer, Robert C., et al.. (2007). Dual-role self-assembling nanoplexes for efficient gene transfection and sustained gene delivery. Biomaterials. 29(5). 607–617. 26 indexed citations
8.
Unfer, Robert C., et al.. (2006). Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy. Gene Therapy. 13(13). 1052–1056. 20 indexed citations
9.
Unfer, Robert C., et al.. (2006). Investigation ofin vitrobiocompatibility of novel pentablock copolymers for gene delivery. Journal of Biomedical Materials Research Part A. 81A(1). 24–39. 18 indexed citations
10.
Wright, Simon K., et al.. (2006). Adipophilin induction, lipid accumulation, and anti-proliferation through PPAR-gamma activation in malignant melanoma. 66. 320–320. 1 indexed citations
11.
Rossi, Gabriela R., Robert C. Unfer, Tatiana Seregina, & Charles J. Link. (2005). Complete protection against melanoma in absence of autoimmune depigmentation after rejection of melanoma cells expressing α(1,3)galactosyl epitopes. Cancer Immunology Immunotherapy. 54(10). 999–1009. 27 indexed citations
12.
Unfer, Robert C., et al.. (2005). Effective Growth Arrest of Human Colon Cancer in Mice, Using Rat Sodium Iodide Symporter and Radioiodine Therapy. Human Gene Therapy. 16(11). 1333–1337. 6 indexed citations
13.
Rossi, Gabriela R., Mario R. Mautino, Robert C. Unfer, et al.. (2005). Effective Treatment of Preexisting Melanoma with Whole Cell Vaccines Expressing α(1,3)-Galactosyl Epitopes. Cancer Research. 65(22). 10555–10561. 65 indexed citations
14.
Unfer, Robert C., et al.. (2004). Novel cationic pentablock copolymers as non-viral vectors for gene therapy. Journal of Controlled Release. 103(1). 245–258. 61 indexed citations
15.
Unfer, Robert C., et al.. (2004). Rat Sodium Iodide Symporter for Radioiodide Therapy of Cancer. Clinical Cancer Research. 10(20). 6969–6976. 19 indexed citations
16.
Unfer, Robert C., et al.. (2003). Immunity to the alpha(1,3)galactosyl epitope provides protection in mice challenged with colon cancer cells expressing alpha(1,3)galactosyl-transferase: a novel suicide gene for cancer gene therapy.. PubMed. 63(5). 987–93. 24 indexed citations
17.
Tyler, Robert Claude, Karen A. Fagan, Robert C. Unfer, et al.. (1999). Vascular inflammation inhibits gene transfer to the pulmonary circulation in vivo. American Journal of Physiology-Lung Cellular and Molecular Physiology. 277(6). L1199–L1204. 7 indexed citations
18.
Wasmoen, Terri, et al.. (1995). Protection of Cats from Infectious Peritonitis by Vaccination with a Recombinant Raccoon Poxvirus Expressing the Nucleocapsid Gene of Feline Infectious Peritonitis Virus. Advances in experimental medicine and biology. 380. 221–228. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026